#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15668	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2148	724.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1512	1512	C	901	C	831	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28788	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3579	802.2	0	.	n	.	0	T695C	SNP	695	695	T	1020	1020	C	884	C,T	816,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28788	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3579	802.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1662	1662	A	997	A	917	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28788	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3579	802.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	961	C	892	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28788	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3579	802.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2922	2922	T	896	T,C	832,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28788	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3579	802.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	946	A	878	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	V36A	NONSYN	106	108	GTG	386	388	GCG	241;242;244	G;C;G	220;221;222	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	428	430	CGG	230;223;223	C;G;G	209;201;199	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	S68L	NONSYN	202	204	TCG	482	484	TTG	189;188;188	T,G;T;G	171,1;176;177	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	A90V	NONSYN	268	270	GCG	548	550	GTT	176;176;177	G;T;T	163;163;166	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	I105V	NONSYN	313	315	ATT	593	595	GTT	179;180;179	G;T;T	173;170;171	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	N125T	NONSYN	373	375	AAT	653	655	ACC	203;202;201	A,T;C;C	182,1;186;185	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	R135C	NONSYN	403	405	CGT	683	685	TGT	225;227;225	T;G;T,C	195;204;197,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	K151E	NONSYN	451	453	AAA	731	733	GAA	210;211;209	G;A;A	196;196;195	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	734	736	AAC	206;203;202	A;A,C;C	194;192,1;188	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	A172T	NONSYN	514	516	GCG	794	796	ACA	166;169;167	A;C;A	159;164;160	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	A175E	NONSYN	523	525	GCG	803	805	GAA	174;174;176	G;A;A	167;165;166	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	E176T	NONSYN	526	528	GAA	806	808	ACC	179;182;178	A;C;C	167;172;170	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	I178V	NONSYN	532	534	ATC	812	814	GTC	177;179;180	G;T;C	168;168;171	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	I188T	NONSYN	562	564	ATA	842	844	ACG	184;185;186	A;C;G	164;169;166	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	P200N	NONSYN	598	600	CCC	878	880	AAC	183;185;187	A;A;C	173;174;177	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	F220L	NONSYN	658	660	TTT	938	940	TTG	205;205;205	T;T;G,T	181;182;186,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	A239T	NONSYN	715	717	GCA	995	997	ACC	194;197;199	A,G;C;C,G	177,1;182;180,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	N240D	NONSYN	718	720	AAT	998	1000	GAC	199;200;199	G;A;C	183;178;181	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1007	1009	GCG	197;197;195	G;C;G	182;154;178	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1043	1045	GCT	161;163;163	G,T;C;T,C	148,1;152;148,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1954	folP	858	858	91.61	folP.l15.c30.ctg.1	1434	135.3	1	SNP	p	R230S	1	.	.	688	690	AGC	968	970	AGC	225;223;222	A;G;C	206;208;206	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6032	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3449	174.3	1	SNP	p	S91F	0	.	.	271	273	TCC	589	591	TCC	201;201;201	T;C;C,A	186;189;190,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6032	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3449	174.3	1	SNP	p	D95G	0	.	.	283	285	GAC	601	603	GAC	194;193;189	G;A;C	183;181;178	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6032	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3449	174.3	1	SNP	p	D95N	0	.	.	283	285	GAC	601	603	GAC	194;193;189	G;A;C	183;181;178	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1934	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1347	142.5	1	SNP	p	G45D	1	.	.	133	135	GAC	428	430	GAC	239;241;242	G;A,G;C	221;222,1;228	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1002	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	991	100.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5634	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	195.4	1	SNP	p	D86N	0	.	.	256	258	GAC	544	546	GAC	241;240;239	G;A;C	221;216;216	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5634	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	195.4	1	SNP	p	S87I	0	.	.	259	261	AGT	547	549	AGT	237;236;241	A;G;T	215;214;218	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5634	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	195.4	1	SNP	p	S87R	0	.	.	259	261	AGT	547	549	AGT	237;236;241	A;G;T	215;214;218	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5634	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	195.4	1	SNP	p	S87W	0	.	.	259	261	AGT	547	549	AGT	237;236;241	A;G;T	215;214;218	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5634	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2867	195.4	1	SNP	p	S88P	0	.	.	262	264	TCC	550	552	TCC	238;240;238	T;C;C	221;220;217	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4688	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2605	179.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1558	1560	GGC	222;220;215	G;G;C,T	207;200;203,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1245	1247	GCA	237;239;241	G;C;A,C	219;222;224,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1248	1250	ATC	245;243;244	A;T;C,G	227;223;221,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1260	1262	GTG	240;243;239	G,A;T;G	223,1;224;220	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1260	1262	GTG	240;243;239	G,A;T;G	223,1;224;220	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1764	1766	ACC	201;199;201	A;C,T;C	183;183,1;186	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1818	1820	GCG	213;215;218	G;C,A;G	183;171,1;182	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1818	1820	GCG	213;215;218	G;C,A;G	183;171,1;182	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1941	1943	GGC	162;162;159	G;G;C,A	149;149;143,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1950	1952	GGC	156;155;152	G;G;C	138;138;136	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4226	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	166.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1968	1970	CCG	136;139;142	C,G;C,G;G	93,4;98,2;103	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6194	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3137	196.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2670	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1834	144.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	599	599	C	192	C,G	181,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	456	458	GAA	204;201;199	G;A;A	193;190;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	S46G	NONSYN	136	138	AGC	480	482	GGC	204;204;207	G;G,T;C,T	194;193,1;198,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	486	488	GGA	208;208;207	G;G;A	198;198;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	T87A	NONSYN	259	261	ACT	603	605	GCT	222;222;223	G,A;C;T	205,2;206;206	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	609	611	AGC	219;212;213	A;G,C;C,A	205;196,1;197,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	701	702	CG	235;232	C,T;G	221,1;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	704	706	CAG	232;231;229	C;A;G	218;214;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	708	710	AAA	230;230;230	A;A;A	216;217;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	771	773	GAA	222;222;225	G,A,C;A,G;A	200,1,1;199,1;202	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	795	797	GCA	239;240;241	G;C,T;A	216;217,1;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	A215T	NONSYN	643	645	GCT	987	989	ACT	226;226;224	A,T;C,T,A;T	215,2;213,1,1;212	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	I218M	NONSYN	652	654	ATA	996	998	ATG	219;215;214	A;T;G,C	208;206;203,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1110	1112	GCA	221;221;223	G;C;A	206;207;210	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1113	1115	ACG	219;217;218	A;C;G	206;204;202	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	S258R	NONSYN	772	774	AGT	1116	1118	AGG	219;215;218	A;G;G	197;195;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1119	1121	GTT	214;216;216	G;T;T	194;193;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1179	1181	GTA	236;232;230	G;T,C;A	224;220,1;218	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1218	1220	ACT	247;248;247	A;C;T	231;231;228	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1224	1226	GAT	245;244;242	G;A;T	223;223;222	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1236	1238	CAC	235;235;238	CA,C;A;C	224,1;213;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	1	SNP	p	G120K	1	.	.	358	360	AAG	701	703	CGG	235;232;229	C,T;G;G	221,1;216;215	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	1	SNP	p	D121N	0	.	.	361	363	GAC	704	707	CGC	232;229;228	C;G;C,T	218;213;212,1	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2746	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1525	179.0	1	SNP	p	A121D	1	.	.	361	363	GAC	704	707	CGC	232;229;228	C;G;C,T	218;213;212,1	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10762	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	4792	224.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1976	1978	CAT	233;235;233	C;A;T	218;218;218	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1214	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	967	123.9	1	SNP	p	V57M	1	.	.	169	171	ATG	449	451	ATG	246;247;246	A;T;G	224;226;227	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
